These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 11979370)
1. Regulation of proliferation/apoptosis equilibrium by mitogen-activated protein kinases in normal, hyperplastic, and carcinomatous human prostate. Royuela M; Arenas MI; Bethencourt FR; Sánchez-Chapado M; Fraile B; Paniagua R Hum Pathol; 2002 Mar; 33(3):299-306. PubMed ID: 11979370 [TBL] [Abstract][Full Text] [Related]
2. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. Magi-Galluzzi C; Mishra R; Fiorentino M; Montironi R; Yao H; Capodieci P; Wishnow K; Kaplan I; Stork PJ; Loda M Lab Invest; 1997 Jan; 76(1):37-51. PubMed ID: 9010448 [TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: parallelism with c-myc and p53 expression. Royuela M; de Miguel MP; Ruiz A; Fraile B; Arenas MI; Romo E; Paniagua R Eur Cytokine Netw; 2000 Mar; 11(1):119-27. PubMed ID: 10705309 [TBL] [Abstract][Full Text] [Related]
4. Immune profiling of human prostate epithelial cells determined by expression of p38/TRAF-6/ERK MAP kinases pathways. Bouraoui Y; Achour M; Royuela M; Oueslati R Kaohsiung J Med Sci; 2018 Mar; 34(3):125-133. PubMed ID: 29475459 [TBL] [Abstract][Full Text] [Related]
5. Pro-apoptotic tumor necrosis factor-alpha transduction pathway in normal prostate, benign prostatic hyperplasia and prostatic carcinoma. Ricote M; Royuela M; García-Tuñón I; Bethencourt FR; Paniagua R; Fraile B J Urol; 2003 Sep; 170(3):787-90. PubMed ID: 12913698 [TBL] [Abstract][Full Text] [Related]
6. Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase. Youn DH; Park J; Kim HL; Jung Y; Kang J; Jeong MY; Sethi G; Seok Ahn K; Um JY Oncotarget; 2017 Feb; 8(6):9500-9512. PubMed ID: 27880726 [TBL] [Abstract][Full Text] [Related]
7. The p38 transduction pathway in prostatic neoplasia. Ricote M; García-Tuñón I; Bethencourt F; Fraile B; Onsurbe P; Paniagua R; Royuela M J Pathol; 2006 Feb; 208(3):401-7. PubMed ID: 16369914 [TBL] [Abstract][Full Text] [Related]
8. Relationship between IL-6/ERK and NF-κB: a study in normal and pathological human prostate gland. Rodríguez-Berriguete G; Prieto A; Fraile B; Bouraoui Y; de Bethencourt FR; Martínez-Onsurbe P; Olmedilla G; Paniagua R; Royuela M Eur Cytokine Netw; 2010 Dec; 21(4):241-50. PubMed ID: 21081304 [TBL] [Abstract][Full Text] [Related]
9. Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate. Royuela M; de Miguel MP; Bethencourt FR; Sánchez-Chapado M; Fraile B; Arenas MI; Paniagua R J Endocrinol; 2001 Mar; 168(3):447-54. PubMed ID: 11241176 [TBL] [Abstract][Full Text] [Related]
10. Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Kyprianou N; Tu H; Jacobs SC Hum Pathol; 1996 Jul; 27(7):668-75. PubMed ID: 8698310 [TBL] [Abstract][Full Text] [Related]
11. Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cells. Uzgare AR; Isaacs JT Cancer Res; 2004 Sep; 64(17):6190-9. PubMed ID: 15342404 [TBL] [Abstract][Full Text] [Related]
12. Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases. Xiao D; Singh SV Cancer Res; 2002 Jul; 62(13):3615-9. PubMed ID: 12097262 [TBL] [Abstract][Full Text] [Related]
13. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium. Chuang SM; Wang IC; Yang JL Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022 [TBL] [Abstract][Full Text] [Related]
14. NELL2 modulates cell proliferation and apoptosis via ERK pathway in the development of benign prostatic hyperplasia. Liu J; Liu D; Zhang X; Li Y; Fu X; He W; Li M; Chen P; Zeng G; DiSanto ME; Wang X; Zhang X Clin Sci (Lond); 2021 Jul; 135(13):1591-1608. PubMed ID: 34195782 [TBL] [Abstract][Full Text] [Related]
15. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment]. Zhang YX; Kong CZ Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842 [TBL] [Abstract][Full Text] [Related]
16. Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate. Rodríguez-Berriguete G; Fraile B; de Bethencourt FR; Prieto-Folgado A; Bartolome N; Nuñez C; Prati B; Martínez-Onsurbe P; Olmedilla G; Paniagua R; Royuela M BMC Cancer; 2010 Jan; 10():18. PubMed ID: 20078866 [TBL] [Abstract][Full Text] [Related]
17. Aromatase in hyperplasia and carcinoma of the human prostate. Hiramatsu M; Maehara I; Ozaki M; Harada N; Orikasa S; Sasano H Prostate; 1997 May; 31(2):118-24. PubMed ID: 9140125 [TBL] [Abstract][Full Text] [Related]
18. TNF/IL-1/NIK/NF-kappa B transduction pathway: a comparative study in normal and pathological human prostate (benign hyperplasia and carcinoma). Nuñez C; Cansino JR; Bethencourt F; Pérez-Utrilla M; Fraile B; Martínez-Onsurbe P; Olmedilla G; Paniagua R; Royuela M Histopathology; 2008 Aug; 53(2):166-76. PubMed ID: 18752500 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis. Matsuyama M; Hayama T; Funao K; Kawahito Y; Sano H; Takemoto Y; Nakatani T; Yoshimura R Oncol Rep; 2007 Jul; 18(1):99-104. PubMed ID: 17549353 [TBL] [Abstract][Full Text] [Related]
20. Saw palmetto extract suppresses insulin-like growth factor-I signaling and induces stress-activated protein kinase/c-Jun N-terminal kinase phosphorylation in human prostate epithelial cells. Wadsworth TL; Carroll JM; Mallinson RA; Roberts CT; Roselli CE Endocrinology; 2004 Jul; 145(7):3205-14. PubMed ID: 15033918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]